• Contact Us
  • About
  • Advertise
  • Careers
Kashmir Dot Com
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us
No Result
View All Result
Kashmir Dot Com
No Result
View All Result
Home Health

DAK Seeks Compulsory Licensing For Covid-19 Vaccine, Drugs

Kashmir Dot Com by Kashmir Dot Com
May 10, 2021
in Health, JAMMU, Kashmir
0
Vaccine only way to end Covid-19 pandemic: DAK

President and influenza expert Dr Nisar ul Hassan

0
SHARES
35
VIEWS
Share on Facebook

Srinagar, May 10, KDC: Doctors Association Kashmir (DAK) on Monday urged the Union government to grant compulsory license for Covid-19 vaccines and drugs.

“That would make vaccines and life-saving Covid medicines accessible to people and save lives,” said DAK President and influenza expert Dr Nisar ul Hassan in a statement issued to KDC.

“Compulsory licensing is a provision under the patent act that enables a government to allow other pharma companies to produce the patented drugs in times of public health emergency,” he said.

“A pharma company that develops a drug gets patent protection that prohibits other manufacturers from producing the drug for a period of 20 years,” he added.

Dr Hassan said we are in a grave public health crisis and precious lives are being lost each day. The lives of people should take priority over everything else.

“We should go for compulsory licensing now,” he said.

Dr Hassan said in order to respond to the huge demand for vaccines and drugs, there is a need to rapidly upscale production, which can only happen when there are more companies involved in manufacturing and this is possible by issuing compulsory licenses.

He said Tocilizumab, a life-saving drug for Covid is one of the patented drugs for which the government should invoke a compulsory licensing clause.

“The drug which costs Rs 40,000 for a single dose is manufactured by Switzerland based pharma company Roche and is marketed by Cipla in India. Despite being on clinical protocol, there is a shortage of the drug,” he added.

The DAK President said though the patent owner of Remdesivir Gilead, a US based Pharma Company has allowed few Indian pharma houses to produce the drug, there is an increased demand amid severe second wave of the pandemic and we need to permit others to manufacture the drug.

He said in order to reach herd immunity we need to vaccinate three in five and for that the country needs 150 to160 crore doses of the vaccine. And we need them quickly. Currently, India is producing 65 million doses every month,” he said.

“This makes a crying need for patent wavering and granting of compulsory licensing for other manufacturing units to produce the vaccine,” said Dr Nisar.(KDC)

Tags: DAK KAshmir
Previous Post

Covid-19 second wave: Virtual hearing in all courts in J-K, Ladakh extended till 31 May

Next Post

Breaking the chain of transmission is key to containing the surge of positive cases: Dr Khurshid Ahmad Bhat

Next Post
Dr Khurshid

Breaking the chain of transmission is key to containing the surge of positive cases: Dr Khurshid Ahmad Bhat

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

LATEST NEWS

PAYAAM – Craft & Design Bazaar concludes Three-Day Showcase at Jhelum Waterfront

Army Concludes National Integration Tour for 30 Bandipora Students Under Op Sadhbhavana

Farmers Await HDP Target Allocation as Horticulture Department Promises Distribution Within Two Days

J&K to implement 25% reservation for EWS, disadvantaged children in Private Schools soon: Education Minister

Belagavi Mayor-Led Delegation Visits Srinagar to Study Smart City Projects, Appreciates Urban Development Initiatives

J&K High Court directs SSP to produce Commissioner Secretary, Director

CRPF Special DG Visits Srinagar Sector Hqrs, Reviews Operational Preparedness

NIT Srinagar’s faculty member invited to deliver Advanced Course at Prestigious French Research Laboratory

JKSA Seeks CBI Probe into FAA Exam Cheating Allegations, Demands Postponement of JKPSI, Constable Tests

ACB Chargesheets Former TSO, Storekeeper, 13 Dealers in Rs 50 Lakh Ration Scam

Facebook Twitter

About Us

Kashmir Dot Com (KDC) is J&K's premier News Agency having a vast reach of audience.

Kashmir Dot Com is a News Agency based in Srinagar, J&K that offers syndicated multimedia news feed to plethora of news-bureaus in J&K and beyond. We also provide a range of facilities from foreign and domestic channels to package their reports in Jammu and Kashmir. We cover almost all areas of interest in J&K to viewers including news, entertainment, and life styles, bussiness, sports, human-interest features and social and developmental issues.

KDC can well and truly take pride in the legacy of it's work, and in it's contribution towards the building of a free and fair Press in Jammu and Kashmir.

Category

  • Business
  • Entertainment
  • Health
  • JAMMU
  • Kashmir
  • Lead
  • National
  • Opinion
  • Politics
  • Science
  • Sports
  • Tech
  • Uncategorized
  • World

Company Info

  • Contact Us
  • About
  • Advertise
  • Careers

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.

error: Content is protected !!
No Result
View All Result
  • Home
  • Kashmir
  • Jammu
  • World
  • Politics
  • Opinion
  • Business
  • Health
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.